Clinical trial
Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent…
NCT00115999 · ARCA Biopharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00115999 |
|---|---|
| Title | Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries |
| Official title | Phase 3, Multicenter, Multi-National, Randomized, Partial Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Acute Peripheral Arterial Occlusion |
| Lead sponsor | ARCA Biopharma, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Drug |
| Interventions | alfimeprase |
| Enrollment | 300 |
| Start date | Apr 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 27, 2005 |
| Last update posted | Jan 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: